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InTroduCTIon
Takotsubo cardiomyopathy (TC), also known as 
stress cardiomyopathy, and broken heart syndrome 
is characterized by transient left ventricular (LV) apical 
akinesis with symptoms mimicking acute coronary 
syndrome. The first case was described by Sato et al. 
in Japan.1  The Japanese word “takotsubo” translates to 
“octopus pot” describing the shape of the left ventricle 
during systole. TC can be triggered by a “broken heart” 
including death of a loved one, constant anxiety, 
surgery, or critical illness etc. Prevalence is around 2% 
to 3% with over 90% in postmenopausal women aged 
between 58 and 75. Its pathogenesis remains unclear. 
Some postulated that excess catecholamine released 
during stress can induce an exaggerated sympathetic 
response precipitating severe, reversible LV dysfunction 
in patients without coronary disease.2 Whether there is a 
genetic component is not well understood. There are a 
few reported cases of Takotsubo in family members, one 
case of two sisters and another mother-daughter pair.3,4 
Recurrence of the syndrome in the same patient, although 
rare, can occur and suggests a genetic predisposition.5 
Majority of patients regain normal ventricular function 
within one to four weeks if they survive the acute episode. 
Hospital mortality rates range from 0 to 8 %. However, 
one major complication is the risk of intraventricular 
thrombus formation and systemic embolization. Data 
is lacking to guide anticoagulation for LV thrombus 
prevention in patients with stress cardiomyopathy. 
CaSE PrESEnTaTIon
Mrs. S is a 62 year old woman with a prior history of TC 
with full recovery, hyperlipidemia, and gastroesophageal 
reflux disease presented with chest pain radiating to her 
left shoulder. She was under significant financial stress 
during that week. Her pain was unrelieved with aspirin 
or sublingual nitroglycerin. In the emergency room, her 
electrocardiogram showed ST segment elevations in 
leads V2-V6 (Figure 1) with Troponin T 1.49ng/mL. She 
was immediately started on heparin and nitroglycerin 
drips and rushed to the catheterization laboratory. 
Coronary angiography did not reveal significant coronary 
disease but incidentally found elevated pulmonary 
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Figure 1. Mrs. S's initial EKG showing ST segment elevations in leads V2-V6. 
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dISCuSSIon
This case has multiple teaching points. First, it is one 
of the few cases of a patient with a recurrence of 
Takotsubo as well as a twin sister who suffered from the 
same syndrome suggesting a possible genetic predispo-
sition to stress cardiomyopathy. Second, it emphasizes 
the risk of intraventricular thrombus formation and 
systemic embolization in patients with TC and raises the 
important discussion on whether these patients should 
receive prophylactic anticoagulation. 
Familial cases of stress cardiomyopathy are very rare. 
One case reports a 64 year old female diagnosed with 
TC when presented with sudden chest pain, elevated 
cardiac enzymes and ST elevations. Her elder sister 
developed TC one year prior with similar presenting 
symptoms. There are also several other reports of 
sisters with TC. Studies on genetic polymorphisms for 
Takotsubo have been inconclusive. One study found an 
association between patients with TC and beta 1 adreno-
receptor gene polymorphisms, suggesting possible 
genetic disease modifiers for developing TC.6 However, 
a large Australian study did not find any association 
between functional variants in the G-protein-coupled 
receptor kinase 5 genes or the β1-adrenergic receptor 
with the occurrence of the syndrome7. 
More research is also needed to understand the risk 
and prevention of thromboembolism in TC patients. 
In a Japanese study of 21 patients with Takosubo, they 
found that 3 patients (14%) suffered thromboembolism, 
one of which had a LV thrombus. They recommended 
prophylactic anticoagulation for TC patients with severe 
wall motion abnormality to prevent cardioembolic stroke8. 
There are scant data on criteria for prophylactic antico-
agulation to prevent thromboembolism in TC. In patients 
with myocardial infarction, it has been found that 
reperfusion therapy and anticoagulant therapy lowers the 
risk of thrombus formation, which would also lower the 
risk of thrombus embolization. In a 1993 meta-analysis 
in patients who had an anterior MI, the odds ratio of LV 
thrombus in patients treated with fibrinolytic was half 
compared to no fibrinolytic therapy.9 The same study 
also showed that initiating heparin early and for more 
than 48 hours lowered the rate of thrombus formation. 
In a randomized control trial, high dose (12,500 units) 
subcutaneous unfractionated heparin given every 12 
hours for 10 days was associated with lower incidence 
wedge pressures. Upon transfer to the cardiac intensive 
unit, Mrs. S became hypotensive and norepinephrine 
was started. Her transthoracic echocardiogram (TTE) 
revealed moderately decreased LV systolic function 
with an estimated ejection fraction (EF)  of  35%, with 
segmental wall motion abnormalities, mid and distal 
akinesis of the LV and hyperkinesis of basal LV. There was 
a late-peaking LV outflow tract gradient of 77 mm Hg 
consistent with severe, dynamic left ventricular outflow 
tract (LVOT) obstruction.
She had a prior episode of TC when her husband passed 
away three years ago. She also has a twin sister who 
suffered from TC a year ago when she lost her job. 
Unlike Mrs. S, she did not fully recover and required long 
term heart failure management. 
dIFFErEnTIal dIagnoSIS
Takotsubo was at the top of our differential given the 
patient’s personal and family history and recent financial 
stress. The lack of significant coronary disease on LHC 
clinched the diagnosis of stress cardiomyopathy.   
ouTCoME and Follow-uP
Mrs. S was diagnosed with TC with LVOT obstruction 
complicated by cardiogenic shock. The LVOT obstruction 
made treatment particularly difficult given that inotropes 
can worsen the obstruction. Due to tachycardia, she 
was switched from norepinephrine to phenylephrine. 
On day 2, Mrs. S developed hypoxia and was intubated 
and rushed to cath lab for intra-aortic balloon pump 
insertion.  However, the procedure was aborted when 
her right heart catheterization numbers and vital signs 
improved. She continued to recover on supportive care 
and was successfully extubated on day 8. Her repeat 
TTE showed recovery of systolic function (EF 70%) but 
revealed a 2.3 x 1.1 cm LV apical thrombus. Heparin drip 
and warfarin were initiated. On day 9, patient reported 
blurry vision and a left visual field defect that were 
persistent despite wearing her glasses.  Although her 
head CT scan was negative for mass effect or stroke, 
her head MRI revealed a recent punctate infarction in 
the right occipital lobe. In addition, on day 11, Mrs. S 
developed intractable back pain and a CT Abdomen and 
Pelvis showed new wedge-shape perfusion defects in 
the right kidney consistent with infarcts.
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of LV thrombus compared to low dose (5,000 units). 
(11 versus 32 percent).10 Amongst patients who already 
developed a LV thrombus, anticoagulation with 
warfarin lowers the risk of thrombus embolization. An 
observational study of 43 patients with LV thrombus after 
MI found no embolic events in the 25 patients treated 
with anticoagulation compared to 7 of 18 untreated 
patients having an embolic event, all occurring within 
4 months.11 Although no studies have been done 
on patients with stress cardiomyopathy, it would be 
reasonable to initiate anticoagulation in patients with 
severe LV dysfunction to prevent thrombus. 
KEy PoInTS
1. Familial and recurrent cases suggest a genetic 
predisposition to Takotsubo cardiomyopathy.
2. Patients suffering from stress cardiomyopathy with 
severe LV dysfunction may benefit from early antico-
agulation to prevent thromboembolism. 
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